ImmunXperts, a Q² Solutions Company, offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment.
While touring the exhibit and posters through the conference, connect with Sofie Pattijn presenting our poster, # P067. This poster presentation follows a two day immunogenicity pre-conference training lead by our scientists, Sofie Pattijn and Chloe Ackaert.
PEGS Boston Conference and Expo starts this week. Cambridge Healthtech Institute launches this week with a series of workshops. This year's Introduction to Immunogenicity session will be presented by Sofie Pattijn and Chloe Ackaert. Full seminar agenda, https://t.co/2v5m4WfgWF
Earlier this week Sofie Pattijn and Chloe Ackaert joined immunogenicity experts for a global event to address challenges, best practices, and strategies. We presented during the Prediction of Immunogenicity session.
In New Orleans, LA this weekend, scientists Thibaut Janss and Simon Lefevre will attend the American Association for Cancer Research Annual Meeting. Stop by the Q² Solutions Booth #3329 or meet with these experts during any of our four poster presentations.
Early development and candidate selection phases rely on a data driven approach to inform next stages of the therapeutic development cycle. Find out how utilization of in vitro bioassays is critical to understanding a molecule’s immunogenic potential, https://t.co/RXZNLDFSf7
It's #EuropeanResearchersNight! Make sure to check some of the cool science events organised across Europe today, especially the @meetme2night event in Milan, as @BactiVax will be there! Today @5pm CET & tomorrow @4pm we'll have interactive sessions on vaccine discovery. Link⬇️
3 days, 58 participants, 15 excellent ESR presentations, 6 scientific & training sessions, and our kick-off meeting was a success! Huge thanks to our speakers and to all who attended. #VaccinesWork@mcclean_siobhan@HuebnerJohannes@REA_research @MSCActions @EU_H2020
Last but not least we have Lorenzo, our Project 15 Researcher! Lorenzo will be hosted by @immunxperts and will focus on developing in vitro assays to evaluate new vaccine candidates.
👨🔬https://t.co/MhQvCsRoe5 @LorenzoBossi5#VaccinesWork@REA_research@mcclean_siobhan @MSCActions
Time to come together, leverage every resource for the greater good!
Nexelis, @ImmunXperts and @PHE_uk experts are working together on speeding up the development of vaccines and therapeutics https://t.co/EurVT7Et34 via @xtalks